140 related articles for article (PubMed ID: 38257194)
1. Evaluation of the Antibacterial, Anti-Cervical Cancer Capacity, and Biocompatibility of Different Graphene Oxides.
Castro JI; Payan-Valero A; Valencia-Llano CH; Insuasty D; Rodríguez Macias JD; Ordoñez A; Valencia Zapata ME; Mina Hernández JH; Grande-Tovar CD
Molecules; 2024 Jan; 29(2):. PubMed ID: 38257194
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress-mediated antibacterial activity of graphene oxide and reduced graphene oxide in Pseudomonas aeruginosa.
Gurunathan S; Han JW; Dayem AA; Eppakayala V; Kim JH
Int J Nanomedicine; 2012; 7():5901-14. PubMed ID: 23226696
[TBL] [Abstract][Full Text] [Related]
3. Click synthesis of quaternized poly(dimethylaminoethyl methacrylate) functionalized graphene oxide with improved antibacterial and antifouling ability.
Tu Q; Tian C; Ma T; Pang L; Wang J
Colloids Surf B Biointerfaces; 2016 May; 141():196-205. PubMed ID: 26852103
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, Characterization, and Bactericidal Evaluation of Chitosan/Guanidine Functionalized Graphene Oxide Composites.
Li P; Gao Y; Sun Z; Chang D; Gao G; Dong A
Molecules; 2016 Dec; 22(1):. PubMed ID: 28025561
[TBL] [Abstract][Full Text] [Related]
5. Preparation, characterization, and antibacterial activity of silver nanoparticle-decorated graphene oxide nanocomposite.
Shao W; Liu X; Min H; Dong G; Feng Q; Zuo S
ACS Appl Mater Interfaces; 2015 Apr; 7(12):6966-73. PubMed ID: 25762191
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial properties of nanoporous graphene oxide/cobalt metal organic framework.
Hatamie S; Ahadian MM; Soufi Zomorod M; Torabi S; Babaie A; Hosseinzadeh S; Soleimani M; Hatami N; Wei ZH
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109862. PubMed ID: 31500010
[TBL] [Abstract][Full Text] [Related]
7. Synergistic antibacterial effect of tetracycline hydrochloride loaded functionalized graphene oxide nanostructures.
Jiang L; Su C; Ye S; Wu J; Zhu Z; Wen Y; Zhang R; Shao W
Nanotechnology; 2018 Dec; 29(50):505102. PubMed ID: 30251959
[TBL] [Abstract][Full Text] [Related]
8. Graphene oxide-silver nanocomposite as a highly effective antibacterial agent with species-specific mechanisms.
Tang J; Chen Q; Xu L; Zhang S; Feng L; Cheng L; Xu H; Liu Z; Peng R
ACS Appl Mater Interfaces; 2013 May; 5(9):3867-74. PubMed ID: 23586616
[TBL] [Abstract][Full Text] [Related]
9. Graphene oxide: a nonspecific enhancer of cellular growth.
Ruiz ON; Fernando KA; Wang B; Brown NA; Luo PG; McNamara ND; Vangsness M; Sun YP; Bunker CE
ACS Nano; 2011 Oct; 5(10):8100-7. PubMed ID: 21932790
[TBL] [Abstract][Full Text] [Related]
10. Lateral dimension-dependent antibacterial activity of graphene oxide sheets.
Liu S; Hu M; Zeng TH; Wu R; Jiang R; Wei J; Wang L; Kong J; Chen Y
Langmuir; 2012 Aug; 28(33):12364-72. PubMed ID: 22827339
[TBL] [Abstract][Full Text] [Related]
11. Poly-L-lysine-modified reduced graphene oxide stabilizes the copper nanoparticles with higher water-solubility and long-term additively antibacterial activity.
Ouyang Y; Cai X; Shi Q; Liu L; Wan D; Tan S; Ouyang Y
Colloids Surf B Biointerfaces; 2013 Jul; 107():107-14. PubMed ID: 23475058
[TBL] [Abstract][Full Text] [Related]
12. Toxicity of graphene oxide on intestinal bacteria and Caco-2 cells.
Nguyen TH; Lin M; Mustapha A
J Food Prot; 2015 May; 78(5):996-1002. PubMed ID: 25951396
[TBL] [Abstract][Full Text] [Related]
13. Bacterial physiology is a key modulator of the antibacterial activity of graphene oxide.
Karahan HE; Wei L; Goh K; Liu Z; Birer Ö; Dehghani F; Xu C; Wei J; Chen Y
Nanoscale; 2016 Oct; 8(39):17181-17189. PubMed ID: 27722381
[TBL] [Abstract][Full Text] [Related]
14. Biosynthesis and characterization of graphene by using non-toxic reducing agent from Allium Cepa extract: Anti-bacterial properties.
Noorunnisa Khanam P; Hasan A
Int J Biol Macromol; 2019 Apr; 126():151-158. PubMed ID: 30584937
[TBL] [Abstract][Full Text] [Related]
15. Production of Reduced Graphene Oxide by Using Three Different Microorganisms and Investigation of Their Cell Interactions.
Utkan G; Yumusak G; Tunali BC; Ozturk T; Turk M
ACS Omega; 2023 Aug; 8(34):31188-31200. PubMed ID: 37663476
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin-assisted green synthesis of reduced graphene oxide for antimicrobial applications.
Xu LQ; Liao YB; Li NN; Li YJ; Zhang JY; Wang YB; Hu XF; Li CM
J Colloid Interface Sci; 2018 Mar; 514():733-739. PubMed ID: 29316529
[TBL] [Abstract][Full Text] [Related]
17. Toxicity of graphene and graphene oxide nanowalls against bacteria.
Akhavan O; Ghaderi E
ACS Nano; 2010 Oct; 4(10):5731-6. PubMed ID: 20925398
[TBL] [Abstract][Full Text] [Related]
18. Bactericidal effect of graphene oxide/Cu/Ag nanoderivatives against Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus and Methicillin-resistant Staphylococcus aureus.
JankauskaitĿ V; VitkauskienĿ A; Lazauskas A; Baltrusaitis J; ProsyĿevas I; AndruleviĿius M
Int J Pharm; 2016 Sep; 511(1):90-97. PubMed ID: 27370911
[TBL] [Abstract][Full Text] [Related]
19. In situ sonochemical reduction and direct functionalization of graphene oxide: A robust approach with thermal and biomedical applications.
Maktedar SS; Mehetre SS; Avashthi G; Singh M
Ultrason Sonochem; 2017 Jan; 34():67-77. PubMed ID: 27773294
[TBL] [Abstract][Full Text] [Related]
20. Poly(propylene fumarate)/Polyethylene Glycol-Modified Graphene Oxide Nanocomposites for Tissue Engineering.
Díez-Pascual AM; Díez-Vicente AL
ACS Appl Mater Interfaces; 2016 Jul; 8(28):17902-14. PubMed ID: 27383639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
